Investigational New Drug Exemptions in Spotlight of Research Q&A
A UAMS Update article about Research Q-and-A

Home
AUG. 14, 2003 | The August Question-and-Answer Forum sponsored by the UAMS Office of Research Compliance (ORC) will focus on investigational new drug exemptions (INDs). "The A to Z of INDs" will be a 50-minute discussion beginning at 10:00 A.M. in Room G-225 of Education Building III. The presenters will be Edith Paal, ORC clinical research auditor, and Carole Hamon, research regulatory compliance specialist in the Arkansas Children’s Hospital Research Institute. They will explore the concept of INDs and discuss when a research study needs them. Other topics the 50-minute presentation is expected to touch on include general principles of drug development, and regulatory risks and responsibilities when an investigator holds a new drug exemption. The forum is one of a monthly series of question-and-answer sessions for principal investigators, coordinators, and staff involved in human subject research. The next in the series, in September, will look at changes in the regulatory environment of human subject research.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software

This article has been moved here